ZYNE logo

Zynerba Pharmaceuticals (ZYNE) Long Term Liabilities

ZYNE Annual Total Long Term Liabilities

$119.50 K
-$234.20 K-66.21%

31 December 2022

ZYNE Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ZYNE Quarterly Long Term Liabilities

$0.00
-$60.00 K-100.00%

30 June 2023

ZYNE Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ZYNE Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-66.2%-100.0%
3 y3 years+8.9%0.0%
5 y5 years-82.0%-100.0%

ZYNE Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-99.3%-100.0%

Zynerba Pharmaceuticals Long Term Liabilities History

DateAnnualQuarterly
June 2023
-
$0.00(-100.0%)
Mar 2023
-
$60.00 K(-49.8%)
Dec 2022
$119.50 K(-66.2%)
$119.50 K(-33.1%)
Sept 2022
-
$178.70 K(-24.7%)
June 2022
-
$237.40 K(-19.7%)
Mar 2022
-
$295.80 K(-16.4%)
Dec 2021
$353.70 K(>+9900.0%)
$353.70 K(-14.0%)
Sept 2021
-
$411.20 K(-12.2%)
June 2021
-
$468.40 K(-10.8%)
Mar 2021
-
$525.10 K(>+9900.0%)
Dec 2020
$0.00(-100.0%)
$0.00(0.0%)
Sept 2020
-
$0.00(0.0%)
June 2020
-
$0.00(-100.0%)
Mar 2020
-
$44.20 K(-59.7%)
Dec 2019
$109.70 K(>+9900.0%)
$109.70 K(>+9900.0%)
Sept 2019
-
$0.00(0.0%)
June 2019
-
$0.00(-100.0%)
Mar 2019
-
$20.60 K(>+9900.0%)
DateAnnualQuarterly
Dec 2018
$0.00(-100.0%)
$0.00(0.0%)
Sept 2018
-
$0.00(-100.0%)
June 2018
-
$834.00 K(+26.0%)
Mar 2018
-
$662.00 K(0.0%)
Dec 2017
$662.00 K(>+9900.0%)
$662.00 K(>+9900.0%)
Sept 2017
-
$0.00(0.0%)
June 2017
-
$0.00(0.0%)
Mar 2017
-
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(-100.0%)
Sept 2016
-
$463.40 K(>+9900.0%)
June 2016
-
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
Dec 2015
$0.00(-100.0%)
$0.00(0.0%)
Sept 2015
-
$0.00(-100.0%)
June 2015
-
$16.52 M(>+9900.0%)
Mar 2015
-
$0.00(-100.0%)
Dec 2014
$16.52 M(+1005.1%)
$16.52 M
Dec 2013
$1.50 M
-

FAQ

  • What is Zynerba Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Zynerba Pharmaceuticals?
  • What is Zynerba Pharmaceuticals annual total long term liabilities year-on-year change?
  • What is Zynerba Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Zynerba Pharmaceuticals?
  • What is Zynerba Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Zynerba Pharmaceuticals annual total long term liabilities?

The current annual total long term liabilities of ZYNE is $119.50 K

What is the all time high annual total long term liabilities for Zynerba Pharmaceuticals?

Zynerba Pharmaceuticals all-time high annual total long term liabilities is $16.52 M

What is Zynerba Pharmaceuticals annual total long term liabilities year-on-year change?

Over the past year, ZYNE annual total long term liabilities has changed by -$234.20 K (-66.21%)

What is Zynerba Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of ZYNE is $0.00

What is the all time high quarterly long term liabilities for Zynerba Pharmaceuticals?

Zynerba Pharmaceuticals all-time high quarterly total long term liabilities is $16.52 M

What is Zynerba Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, ZYNE quarterly total long term liabilities has changed by -$237.40 K (-100.00%)